CARMEL, Ind.--(BUSINESS WIRE)--ParaPRO LLC announced today that two phase 3 clinical trails have begun for its lead investigational product, a crème rinse containing Spinosad, for the treatment of human head lice. The product, tentatively branded NatrOVA™, is being tested in the following 12 regions:
